Salivary gland disease in the era of COVID-19 pandemic.

Authors

• Liuba Soldatova
• Christopher H Rassekh
• Zubair W Baloch
• Jalal B Jalaly
• Neda I Sedora-Roman
• Laurie L Loevner
• David M Cognetti
• Robert L Witt
• Pavel Dulguerov

Publication/Presentation Date

6-1-2020

Abstract

Coronavirus disease 2019 (COVID-19) pandemic forced significant changes in current approach to outpatient evaluation of common otolaryngology complaints as hospitals around the world are trying to limit the spread of the virus and to preserve health care resources. These changes raise a lot of questions regarding patient triage and treatment decisions in clinical situations when it is unclear if the workup and management can be postponed. In this communication, we present our approach to evaluation and triage of new patients with complaints concerning for salivary gland disease.

Volume

42

Issue

6

First Page

1339

Last Page

1343

ISSN

1097-0347

Published In/Presented At

Soldatova, L., Rassekh, C. H., Baloch, Z. W., Jalaly, J. B., Sedora-Roman, N. I., Loevner, L. L., Cognetti, D. M., Witt, R. L., & Dulguerov, P. (2020). Salivary gland disease in the era of COVID-19 pandemic. Head & neck, 42(6), 1339–1343. https://doi.org/10.1002/hed.26210

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

32343454

Department(s)

Administration and Leadership

Document Type

Article